Successful treatment of severe passenger lymphocyte syndrome with efgartigimod synergy
DISCUSSION: The synergistic effect of efgartigimod with eltrombopag and romiplostim most likely resolved the patient's thrombocytopenia. This case represents a novel use of efgartigimod in the treatment of passenger lymphocyte syndrome following liver transplant.PMID:38425280 | DOI:10.1111/trf.17748
Source: Transfusion - Category: Hematology Authors: R Christopher Chase Andree H Koop Marwan Shaikh Robin J Imperial Denise M Harnois Nicole M Loo Jennifer J O'Brien Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Emergency Medicine | Genetics | Hematology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Rituxan | Splenectomy | Thrombocytopenia | Thrombosis | Transplant Surgery | Transplants | Urology & Nephrology